Detalles de la búsqueda
1.
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
Br J Haematol
; 196(3): 606-616, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775591
2.
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Eur J Haematol
; 109(6): 728-735, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056778
3.
Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Eur J Haematol
; 108(5): 403-412, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090068
4.
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Infection
; 50(4): 925-932, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182355
5.
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine.
Eur J Haematol
; 107(2): 202-210, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33960535
6.
Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.
Leukemia
; 36(3): 772-780, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628472
7.
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Lancet Haematol
; 8(4): e278-e288, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770483
8.
Reduced awareness for apraxic deficits in left hemisphere stroke.
Neuropsychology
; 32(4): 509-515, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29672072
9.
PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma.
Leuk Lymphoma
; 61(2): 251-254, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31942807
Resultados
1 -
9
de 9
1
Próxima >
>>